Results 51 to 60 of about 231,965 (320)

Inhibitors of SARS-CoV entry--identification using an internally-controlled dual envelope pseudovirion assay. [PDF]

open access: yes, 2011
Severe acute respiratory syndrome-associated coronavirus (SARS-CoV) emerged as the causal agent of an endemic atypical pneumonia, infecting thousands of people worldwide.
Agudelo, Juliet   +10 more
core   +1 more source

Quantification of drug-induced fractional killing using high-throughput microscopy

open access: yesSTAR Protocols, 2021
Summary: Anti-cancer drugs kill only a fraction of cells within a population at any given time. Here, we describe a protocol to quantify drug-induced fractional killing over time using high-throughput imaging.
Zintis Inde   +2 more
doaj   +1 more source

Optical mapping of neuronal activity during seizures in zebrafish [PDF]

open access: yes, 2017
Mapping neuronal activity during the onset and propagation of epileptic seizures can provide a better understanding of the mechanisms underlying this pathology and improve our approaches to the development of new drugs.
Fornetto, C   +10 more
core   +3 more sources

A system for performing high throughput assays of synaptic function. [PDF]

open access: yesPLoS ONE, 2011
Unbiased, high-throughput screening has proven invaluable for dissecting complex biological processes. Application of this general approach to synaptic function would have a major impact on neuroscience research and drug discovery.
Chris M Hempel   +9 more
doaj   +1 more source

High-content live-cell multiplex screen for chemogenomic compound annotation based on nuclear morphology

open access: yesSTAR Protocols, 2022
Summary: Well-characterized small molecules enable the study of cell processes and facilitate target validation. Here, we describe a high-content multiplex screen to investigate cell viability over 48 h, which can be combined with investigating ...
Amelie Tjaden   +4 more
doaj   +1 more source

A high-throughput and highly automated genotoxicity screening assay

open access: yesALTEX, 2021
The increasing number of compounds under development and chemicals in commerce that require safety assessments pose a serious challenge for regulatory agencies worldwide. In vitro screening using toxicogenomic biomarkers has been proposed as a first-tier screen in chemical assessment and has been endorsed internationally.
Renxiang, Chen   +3 more
openaire   +2 more sources

Optimization of Spectrophotometric and Fluorometric Assays Using Alternative Substrates for the High-Throughput Screening of Lipase Activity

open access: yesJournal of Chemistry, 2021
The effects of reaction conditions on the spectrophotometric and fluorometric assays using alternative substrates (p-nitrophenyl palmitate and 4-methylumbelliferyl oleate) were investigated to optimize them for the high-throughput screening of lipase ...
Jun-Young Park   +4 more
doaj   +1 more source

Identification of Small Molecules that Enhance Synaptogenesis Using Synapse Microarrays [PDF]

open access: yes, 2013
Synaptic function is affected in many brain diseases and disorders. Technologies for large-scale synapse assays can facilitate identification of drug leads.
Ghosh, Balaram   +7 more
core   +1 more source

Organoids in pediatric cancer research

open access: yesFEBS Letters, EarlyView.
Organoid technology has revolutionized cancer research, yet its application in pediatric oncology remains limited. Recent advances have enabled the development of pediatric tumor organoids, offering new insights into disease biology, treatment response, and interactions with the tumor microenvironment.
Carla Ríos Arceo, Jarno Drost
wiley   +1 more source

Protocol to identify receptors of secreted proteins through CRISPR-Cas9 whole-genome screening technology

open access: yesSTAR Protocols
Summary: The interaction between cell surface receptors and their ligands is crucial for intercellular communication. However, current techniques for identifying direct receptor-ligand interactions remain limited.
Xiaoli Hu, Yiguo Wang
doaj   +1 more source

Home - About - Disclaimer - Privacy